Pfizer increases AstraZeneca bid

Science minister David Willetts told BBC Radio 4's Today programme: "We have been having very tough conversations with Pfizer and have made it clear to them that the British Government attaches great importance to the R&D activities happening here in Britain and also manufacturing.

"This is ultimately going to be a decision for AstraZeneca shareholders. But we've made it absolutely clear to Pfizer we have a life sciences strategy, it's aimed at boosting investment in Britain, it's working. We are putting in £1 billion a year of R&D in public money, business has been putting in £1 billion a year in private investment alongside us.

%VIRTUAL-SkimlinksPromo%